Can dapagliflozin cause lactic acidosis?

Dapagliflozin Does Not Directly Cause Lactic Acidosis

Dapagliflozin itself does not cause lactic acidosis—this is not a recognized adverse effect of SGLT2 inhibitors as a drug class. However, the clinical picture becomes more complex when dapagliflozin is combined with metformin, particularly in high-risk situations.

Key Safety Distinction

The FDA drug label for dapagliflozin does not list lactic acidosis as a warning or adverse effect 1. The primary metabolic concern with dapagliflozin is euglycemic diabetic ketoacidosis (DKA), not lactic acidosis 2, 1. Major guidelines consistently identify ketoacidosis—not lactic acidosis—as the metabolic acidosis risk associated with SGLT2 inhibitors 2, 3.

The Metformin Connection

The confusion arises because:

• Metformin causes lactic acidosis when toxic levels accumulate, particularly with eGFR <30 mL/min/1.73 m² 4, 5, 6
• Dapagliflozin and metformin are frequently prescribed together, including as fixed-dose combinations 5, 7
• Both drugs can be used safely down to eGFR 30 mL/min/1.73 m² for dapagliflozin 2, 8 and eGFR ≥30 mL/min/1.73 m² for metformin 6

High-Risk Scenarios for Combined Acidosis

When dapagliflozin and metformin are used together, severe metabolic acidosis can occur through a dual mechanism:

1. Dapagliflozin-induced ketoacidosis (from increased ketogenesis and lipolysis)
2. Metformin-induced lactic acidosis (from impaired lactate clearance)

This combination becomes particularly dangerous when precipitated by:

• Severe dehydration from vomiting/diarrhea 9, 10
• Acute kidney injury (reduces clearance of both drugs) 9, 10
• Volume depletion from SGLT2 inhibitor-induced natriuresis and glycosuria 9, 7
• Fasting or reduced caloric intake 10
• Concurrent heart failure 10

Clinical Recognition

Look for these specific features:

• High anion gap metabolic acidosis with pH potentially <6.7 9
• Elevated lactate (>5 mmol/L, can reach >19 mmol/L) 9, 11
• Elevated beta-hydroxybutyrate (ketoacidosis component) 9, 12
• Blood glucose may be normal or only mildly elevated (euglycemic presentation) 1, 9
• Acute kidney injury with creatinine elevation 9, 10

Management Algorithm

Immediate actions:

1. Discontinue both dapagliflozin and metformin immediately 1, 9
2. Aggressive IV fluid resuscitation (addresses volume depletion from both drugs)
3. Insulin therapy for ketoacidosis component 9
4. Consider renal replacement therapy (hemodialysis or CRRT) for:
   • Severe acidosis (pH <7.0)
   • Lactate >15-20 mmol/L
   • Acute kidney injury with inadequate response to fluids 9, 11, 10
5. Bicarbonate therapy may be needed for severe acidosis 9

Important Caveats

• The actual incidence of severe combined acidosis is extremely rare 9, 7
• Most patients tolerate the combination safely when kidney function is adequate
• Do not restart metformin until eGFR recovers to ≥30 mL/min/1.73 m² and acidosis has completely resolved 11
• Dapagliflozin can be restarted once ketoacidosis resolves and precipitating factors are addressed, as it was not the primary cause of lactic acidosis

Bottom Line

Dapagliflozin does not cause lactic acidosis as a direct drug effect. The risk emerges when combined with metformin in the setting of acute illness causing dehydration and kidney injury, creating a "perfect storm" of dual metabolic acidosis (ketoacidosis + lactic acidosis) 9, 7, 10. Maintain high clinical suspicion in patients on combination therapy who present with severe dehydration or acute kidney injury.